| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-10 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |